Jiajie F. Hou
160 Pujian Rd
Shanghai, 200127, China
Shanghai, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment.
Journal: Molecular cancer
Published: July 04, 2026
Xbp1 controls the reparative function of intestinal ILC2s during colitis.
Journal: The Journal of experimental medicine
Published: February 26, 2025
Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment.
Journal: Molecular cancer
Published: January 31, 2025
Publisher Correction: E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1.
Journal: Acta pharmacologica Sinica
Published: June 20, 2024
YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment.
Journal: Molecular cancer
Published: April 17, 2024
E3 ubiquitin ligase UBR5 modulates circadian rhythm by facilitating the ubiquitination and degradation of the key clock transcription factor BMAL1.
Journal: Acta pharmacologica Sinica
Published: January 01, 2024
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunity.
Journal: Nature communications
Published: December 19, 2023
Noncanonical regulation of HOIL-1 on cancer stemness and sorafenib resistance identifies pixantrone as a novel therapeutic agent for HCC.
Journal: Hepatology (Baltimore, Md.)
Published: April 25, 2023
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells.
Journal: Journal of autoimmunity
Published: September 26, 2022
Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study.
Journal: Journal of hepatocellular carcinoma
Published: June 28, 2022
Last Updated: 09/26/2026